Dyslipidaemia and hyperlipidaemia following renal transplantation

International Urology and Nephrology

Volumn 28, Issue 3, 1996, Pages 419-430

  Locsey L ^a   Asztalos, L ^a   Kincses, Z S ^a   Gyorfi F ^a   Berczi, C S ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE;

ARTICLE; DYSLIPIDEMIA; FEMALE; GRAFT REJECTION; HUMAN; HYPERLIPIDEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE;

EID: 0029788874     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02550506     Document Type: Article

References (28)

1. Bagdade, J., Casaretta, A., Alberts, J.: Effects of chronic uraemia, hemodialysis and renal transplantation on plasma lipids and lipoproteins in man. J. Lab. Clin. Med., 87, 37 (1976).
2. Barbagello, C. M., Averna, M. R., Sparacino, V., Galione, F , Scafldi, V., Amato, S., Mancino, C., Cefalu, A. B., Notarbartolo, A.: Lipoprotein (a) levels in end-stage renal failure and transplantation. Nephron, 64, 560 (1993).
3. Brown, J. H., Anwar, N., Short, C. D., Bhatnager, D., Mackness, M. I., Hunt, L. P., Durrington, P. N.: Serum lipoprotein (a) in renal transplant recipients receiving cyclosporin monotherapy. Nephrol. Dial. Transplant., 8, 863 (1993).
4. Blurnke, M., Keller, E., Eble, F., Nausner, M., Kirste, G.: Obesity in kidney transplant patients as a risk factor. Transplant. P roc., 25, 2618 (1993).
5. Cressman, M. D., Abood, D. O., Neil, J., Hoff, H. F.: Lp (a) and premature mortality during chronic hemodialysis treatment. Chem. Phys. Lipids, 67/68, 419 (1994).
6. Dimeny, B., Tufveson, G., Lithell, H., Larsson, E., Siegbahn, A., Fellstrom, B.: The influence of retransplant lipoprotein abnormalities on the early results of renal transplantation. Eur. J. Clin. Invest., 23, 572 (1993).
7. Domán, J., Pálos, G.: Hyperlipidaemia as a risk factor in the progression of renal diseases (in Hungarian). Magy. Belorv. Arch., 46, 343 (1993).
8. Esterbauer, H., Wag, G., Puhl, H.: Lipid peroxidation and its role in atherosclerosis. Br. Med. Bull., 49, 566 (1993).
9. Fellstrom, B. C., Larsson, E.: Pathogenesis and treatment perspectives of chronic graft rejection (CVR). Immunol. Rev., 134, 83 (1993).
10. Femaris, J. R., Pasqualini, T.: Therapy with a new glucocortocoid: Effect of deflazacort on linear growth and growth hormone secretion in renal transplantation. J. Rheamatol., Suppl., 37, 43 (1993).
11. Galle, J., Schollmeyer, P., Wanner, C.: Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: Influence of the endothelium. Eur. Heart J., 14 (Suppl. 1) 111 (1993).
12. Gill, I. S., Hodge, E. E., Novick, A. C., Steinmuller, D. R., Garred, D.: Impact of obesity on renal transplantation. Transplant. Proc., 25, 1047 (1993).
13. Hricik, D. E., Kupin, W. L., First, M. R.: Steroid free immunosuppression after renal transplantation. J. Am. Soc. Nephrol., 4 (Suppl. 8) S 10 (1994).
14. Isoniemi, H. M., Ahonen, J., Tikkanen, M. J., von Willebrand, E. O., Krogerus, L., Eklund, B. H., Hockerstedt, K. V., Samela, K. E., Hayry, P. J.: Long-term consequences of different immunosuppressive regimens for renal allografts. Transplantation, 55, 494 (1993).
15. Isoniemi, H., Nurminen, M., Tikkanen, M. J., von Willebrand, E., Krogerus, L., Ahonen, J., Eklund, B., Hockerstedt, K., Salmela, K., Hayry, P.: Risk factors predicting chronic rejection of renal allografts. Transplantation, 57, 68 (1994).
16. Johnson, C. P., Gallagher, L. S., Zhu, Y. R., Porth, C., Kelber, S., Roza, A. M., Adams, M. B.: Factors influencing weight gain after renal transplantation. Transplantation, 56, 822 (1993).
17. Kasiske, B. L., Umen, A. J.: Persistent hyperlipidemia in renal transplant patients. Medicine. 66, 309 (1987).
18. Keane, W. F.: Lipids and the kidney. Kidney Int., 46, 910 (1994).
19. Kuster, G. M., Drexel, H., Bleisch, J. A., Rentsch, K., Pei, P., Binswanger, U., Amann, F. W.: Relation of cyclosporine blood levels to adverse effects on lipoproteins. Transplantation, 57, 1479(1994).
20. Mathieu, R. L., Casez, J. P., Jaeger, P., Montandon, A., Peheim, E., Horber, F. F.: Altered body composition and fuel metabolism in stable kidney transplant patients on immunosuppressive monotherapy with cyclosporin-A. Eur. J. Clin Invest., 24, 195 (1994).
21. Maggi, E., Belazzi, R., Falaschi, F., Frattoni, A., Perani, G., Finardi, G., Gazo, A., Nai, M., Romanini, D., Bellomo, G.: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int., 45, 876 (1994).
22. Manske, C. L., Kasiske, B. L.: Lipid abnormalities after renal transplantation. In: Keane, W. F., Stein, J. H. (eds): Contemporary Issues in Nephrology. Vol. 24. Churchill Livingstone, New York 1991, pp. 37-62.
23. Moore, R., Thomas, D., Morgan, E., Wheeler, D., Griffin, P., Salaman, J., Rees, A.: Abnormal lipid and lipoprotein profiles following renal transplantation. Transplant. Proc., 25, 1060 (1993).
24. Pincemail, J., Defraigne, J. O., Franssen, C., Bonnet, P., Deby-Dupont, G., Pirenne, J., Deby, C., Lamy, M., Limet, M., Meurisse, M.: Evidence for free radical formation during human kidney transplantation. Free Radic. Biol. Med., 15, 343 (1993).
25. Rabl, H., Khoschsorur, G., Colombo, T., Petritsch, P., Rauchenwald, M., Koltringer, P., Tatzber, F., Esterbauer, H.: A multivitamin infusion prevents lipid peroxidation and improves transplantation performance. Kidney Int., 43, 912 (1993).
26. Schulak, J. A., Hricik, D. E.: Steroid withdrawal after transplantation. Clin. Transplant., 8, 211 (1994).
27. Traindl, O., Reading, S., Franz, M., Watschinger, B., Klauser, R., Pidlich, H., Wildhahn, K., Pohanka, E., Kovarik, J.: Treatment of hyperlipidemic kidney graft recipients with Lovastatin: Effect on LDL-cholesterol and lipoprotein (a). Nephron, 62, 394 (1992).
28. Webb, A. T., Reaveley, D. A., O'Donnell, M., O'Connor, B., Seed, M., Brown, E. A.: Does cyclosporin increase lipoprotein (a) concentrations in renal transplant recipients? Lancet, 341, 268 (1993).